Volume | 593,644 |
|
|||||
News | - | ||||||
Day High | 14.97 | Low High |
|||||
Day Low | 14.64 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
NeoGenomics Inc | NEO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
14.74 | 14.64 | 14.97 | 14.91 | 14.80 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
9,592 | 593,644 | $ 14.83 | $ 8,804,098 | - | 11.03 - 21.22 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:30:09 | 2 | $ 15.55 | USD |
NeoGenomics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.9B | 127.61M | - | 591.64M | -87.97M | -0.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NeoGenomics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NEO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.91 | 16.12 | 14.48 | 15.15 | 671,626 | -1.00 | -6.29% |
1 Month | 13.62 | 16.12 | 13.34 | 14.68 | 887,138 | 1.29 | 9.47% |
3 Months | 16.87 | 17.11 | 13.34 | 14.95 | 793,956 | -1.96 | -11.62% |
6 Months | 19.42 | 21.22 | 13.34 | 16.19 | 959,130 | -4.51 | -23.22% |
1 Year | 17.99 | 21.22 | 11.03 | 15.67 | 913,668 | -3.08 | -17.12% |
3 Years | 38.34 | 54.74 | 6.00 | 17.65 | 1,175,985 | -23.43 | -61.11% |
5 Years | 22.63 | 61.57 | 6.00 | 23.08 | 1,048,580 | -7.72 | -34.11% |
NeoGenomics Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services. |